Does TOFACITINIB Cause Skin cancer? 488 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 488 reports of Skin cancer have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.3% of all adverse event reports for TOFACITINIB.
488
Reports of Skin cancer with TOFACITINIB
0.3%
of all TOFACITINIB reports
9
Deaths
65
Hospitalizations
How Dangerous Is Skin cancer From TOFACITINIB?
Of the 488 reports, 9 (1.8%) resulted in death, 65 (13.3%) required hospitalization, and 8 (1.6%) were considered life-threatening.
Is Skin cancer Listed in the Official Label?
Yes, Skin cancer is listed as a known adverse reaction in the official FDA drug label for TOFACITINIB.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Skin cancer?
RANITIDINE (5,047)
ADALIMUMAB (1,005)
RISANKIZUMAB-RZAA (831)
INFLIXIMAB (732)
LENALIDOMIDE (572)
RUXOLITINIB (521)
UPADACITINIB (413)
ETANERCEPT (393)
IBRUTINIB (357)
METHOTREXATE (313)
Which TOFACITINIB Alternatives Have Lower Skin cancer Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN